Log in or Sign up for Free to view tailored content for your specialty!
Steatohepatitis/Metabolic Liver Disease News
Echosens, NASHNET collaborate for real-world NAFLD screening study
Echosens announced a pilot study in collaboration with the NASH Network designed to appropriately identify patients with progressive nonalcoholic fatty liver disease using FibroScan, according to a press release.
Fatty liver increases diabetes risk for adults without obesity
Nonalcoholic fatty liver disease is an independent risk factor for diabetes development in adults without obesity, according to findings published in Nutrition, Metabolism and Cardiovascular Diseases.
Log in or Sign up for Free to view tailored content for your specialty!
Gilead announces negative results from phase 3 trial for NASH fibrosis
Results from the STELLAR-4 phase 3 study showed that selonsertib did not meet the pre-specified 48-week endpoint of histologic improvement by 1 or more stage in fibrosis without worsening of nonalcoholic steatohepatitis, according to a press release.
Ethnicity affects propensity for intra-abdominal, hepatic fat storage
Propensity to store fat intra-abdominally varies significantly by ethnicity and race, with higher rates seen in Japanese Americans and lower rates seen in African Americans compared with other groups, according to data published in Gastroenterology.
EASL launches MICROB-PREDICT international microbiome research project
EASL announced the formation and official launch of MICROB-PREDICT, a project designed to research the human microbiome for clinical research and therapeutic development in the field of decompensated cirrhosis and acute-on-chronic liver failure, according to a press release.
Liver disease-related mortality etiology differs by Hispanic subgroups
Among the three largest Hispanic population subgroups, researchers found high levels of heterogeneity in chronic liver disease-related mortality patterns, according to a recently published study.
Experts validate NASH-specific health-related quality of life tool
Researchers validated the disease-specific Chronic Liver Disease Questionnaire for nonalcoholic steatohepatitis, also known as CLDQ-NASH, as a useful health-related quality of life instrument for patients with NASH.
Lobular inflammation in NAFLD affects health-related quality of life
The presence of lobular inflammation in patients with nonalcoholic fatty liver disease correlated with a lower health-related quality of life, along with sex and diabetes, according to a recently published study.
Low sugar diet for pediatric NAFLD improves hepatic steatosis
An 8-week diet low in free sugar content significantly improved hepatic steatosis among adolescent boys with nonalcoholic fatty liver disease compared with their usual diet, according to a study published in JAMA.
Take Home from NASH-TAG: On the precipice of the fatty liver pipeline
by Michael Charlton, MD
-
Headline News
‘Truly alarming’: Life expectancy gap in the US now up to 20 years
November 22, 20243 min read -
Headline News
Autoantibodies present in long COVID, but not a ‘smoking gun’ for new autoimmune disease
November 25, 20242 min read -
Headline News
Cardiovascular disease deaths rising among younger adults living in rural areas
November 15, 20243 min read
-
Headline News
‘Truly alarming’: Life expectancy gap in the US now up to 20 years
November 22, 20243 min read -
Headline News
Autoantibodies present in long COVID, but not a ‘smoking gun’ for new autoimmune disease
November 25, 20242 min read -
Headline News
Cardiovascular disease deaths rising among younger adults living in rural areas
November 15, 20243 min read